|
|
Cvs Health Corporation (CVS) |
|
|
|
| |
CVS's Revenue Growth by Quarter and Year
Cvs Health's Revenue results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| CVS Revenue (in millions $) |
FY 2022 |
FY 2021 |
FY 2020 |
FY 2019 |
| IV Quarter |
December |
-
|
76,604.00
|
69,554.00
|
66,889.00
|
| III Quarter |
September |
-
|
73,794.00
|
67,056.00
|
64,810.00
|
| II Quarter |
June |
-
|
72,616.00
|
65,341.00
|
63,431.00
|
| I Quarter |
March |
76,826.00
|
69,097.00
|
66,755.00
|
61,646.00
|
| FY |
|
76,826.00
|
292,111.00
|
268,706.00
|
256,776.00
|
| CVS Revenue first quarter 2022 Y/Y Growth Comment |
Cvs Health Corporation reported Revenue increase of 11.19% year on year in the first quarter 2022, to $ 76,826.00 millions, this is lower than Cvs Health Corporation's recent average Revenue increase of 15.7%.
Looking into first quarter 2022 results within Pharmacy Services & Retail Drugstore industry 3 other companies have achieved higher Revenue growth. While Cvs Health Corporation' s Revenue growth of 11.19% ranks overall at the positon no. 1589 in the first quarter 2022.
|
| CVS Revenue ( Y/Y Growth %) |
2022
|
2021 |
2020 |
2019 |
| IV Quarter |
December |
- |
10.14 % |
3.98 % |
21.82 % |
| III Quarter |
September |
- |
10.05 % |
3.47 % |
37.11 % |
| II Quarter |
June |
- |
11.13 % |
3.01 % |
35.8 % |
| I Quarter |
March |
11.19 % |
3.51 % |
8.29 % |
34.91 % |
| FY |
|
- |
8.71 % |
4.65 % |
31.96 % |
CVS Revenue (Quarter on Quarter Growth %) |
2022
|
2021 |
2020 |
2019 |
| IV Quarter |
December |
- |
3.81 % |
3.73 % |
3.21 % |
| III Quarter |
September |
- |
1.62 % |
2.62 % |
2.17 % |
| II Quarter |
June |
- |
5.09 % |
-2.12 % |
2.9 % |
| I Quarter |
March |
0.29 % |
-0.66 % |
-0.2 % |
12.27 % |
| FY (Year on Year) |
|
- |
8.71 % |
4.65 % |
31.96 % |
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 96.03 % |
15.7 % |
-6.85 % |
| (June 30. 2007) |
|
(Dec 31 2017) |
|
|
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 96.03 % |
15.7 % |
-6.85 % |
| (June 30. 2007) |
|
(Dec 31 2017) |
|
| Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022 |
Cvs Health's Q/Q Revenue Growth
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 56.98 % |
3.37 % |
-14.3 % |
| (June 30. 2007) |
|
|
| CVS's I. Quarter Q/Q Revenue Comment |
Cvs Health Corporation achieved in the I. Quarter 2022 below company average Revenue growth of 0.29% quarter on quarter, to $ 76,826.00 millions.
Although the I. Quarter 2022 CVS's Revenue Q/Q growth was beneath the ordinary of 3.37 %, that has been still encouraging story, as the I. Quarter surge, outshines the -0.66% Revenue growth in the I. Quarter 2021
Within Pharmacy Services & Retail Drugstore industry 2 other companies have achieved higher Revenue quarter on quarter growth. While Cvs Health's Revenue growth quarter on quarter, overall rank is 1373. |
|
|
|
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 56.98 % |
3.37 % |
-14.3 % |
| (June 30. 2007) |
|
|
| CVS's I. Quarter Q/Q Revenue Comment |
Cvs Health Corporation achieved in the I. Quarter 2022 below company average Revenue growth of 0.29% quarter on quarter, to $ 76,826.00 millions.
I. Quarter 2022 Cvs Health's performance appear to be contradictory, even if beneath the average, yet it demonstrates real acceleration measured to the -0.66% in the I. Quarter 2021 Advaith Saxena , Retail sector contributor allocated in Toronto said.
Within Pharmacy Services & Retail Drugstore industry 2 other companies have achieved higher Revenue quarter on quarter growth. While Cvs Health's Revenue growth quarter on quarter, overall rank is 1373. |
|
Cvs Health's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending
(Mar 31 2022) |
12 Months Ending
(Dec 31 2021) |
12 Months Ending
(Sep 30 2021) |
12 Months Ending
(Jun 30 2021) |
12 Months Ending
(Mar 31 2021) |
| Cumulative Revenue 12 Months Ending |
$ 299,840.00 |
$ 292,111.00 |
$ 285,061.00 |
$ 278,323.00 |
$ 271,048.00 |
| Y / Y Revenue Growth (TTM) |
10.62 % |
8.71 % |
7.15 % |
5.51 % |
3.5 % |
| Year on Year Revenue Growth Overall
Ranking |
# 736 |
# 342 |
# 2329 |
# 2155 |
# 1713 |
| Seqeuential Revenue Change (TTM) |
2.65 % |
2.47 % |
2.42 % |
2.68 % |
0.87 % |
| Seq. Revenue Growth (TTM) Overall
Ranking |
# 617 |
# 2243 |
# 2348 |
# 2643 |
# 2416 |
| Cumulative Revenue growth
Comment |
Although Cvs Health's Annual Revenue growth year on year were below company's average 15.09% , Revenue announced in the Mar 31 2022 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 10.62% year on year, from 8.71% in Dec 31 2021. Cvs Health had also the second highest Revenue growth in Pharmacy Services & Retail Drugstore industry.
Within the Retail sector 30 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 342 to 736. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
21.57 % |
2.84 % |
-32.77 % |
|
|
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
79.63 % |
15.09 % |
-2.35 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 2 |
| Sector |
# 32 |
| S&P 500 |
# 617 |
|
| Cumulative Revenue growth
Comment |
Although Cvs Health's Annual Revenue growth year on year were below company's average 15.09% , Revenue announced in the Mar 31 2022 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 10.62% year on year, from 8.71% in Dec 31 2021. Cvs Health had also the second highest Revenue growth in Pharmacy Services & Retail Drugstore industry.
Within the Retail sector 30 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 342 to 736. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
21.57 % |
2.84 % |
-32.77 % |
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
79.63 % |
15.09 % |
-2.35 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 2 |
| Sector |
# 32 |
| S&P 500 |
# 617 |
|
18.59%